Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Now What? Sanofi CEO Urges Incentives As China Embraces New Drugs

Mar 31 2017

• By Brian Yang

Sanofi CEO Olivier Brandicourt

Related Content

Now Is The Time! Rule Changes To Open Up China To Foreign New Drugs?

Mar 21 2017

Sanofi's Biosimilars Deal With JHL Confirms Growing Trend In China

Dec 16 2016

Gilead Taps New Talent In China Hepatitis Drug Access Drive

Sep 14 2016

Related Companies

Sanofi

Gilead Sciences, Inc.

Bristol Myers Squibb Company

Eden Biologics, Inc.

CStone Pharmaceuticals (Suzhou) Co., Ltd

Harbour BioMed

Additional Topics

China Asia Pacific Policy Reimbursement Pricing Debate Market Access BioPharmaceutical

More from China

More from Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window